UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
February 2, 2021
Date of Report (Date of earliest event reported)
EVIO, Inc.
(Exact name of registrant as specified in its charter)
| Colorado | 000-12350 | 47-1890509 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
2654 W. Horizon Ridge Parkway, Ste B5-208 Henderson, NV | 89052 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (702) 748-9944
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| [ ] | Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.01 Completion of Acquisition or Disposition of Assets.
Effective February 1, 2021, EVIO, Inc. completed the sale of the assets of Smith Scientific Inc. dba EVIO Labs Medford to SSIAC, LLC. The sale was performed in exchange for a combination of cash, assumption of liabilities and forgiveness of debt to Anthony Smith valued at approximately $523,000. The sale was pursuant to the Stipulated Settlement Agreement with the Oregon Liquor Control Commission dated November 19, 2020.
Item 7.01 Regulation FD Disclosure.
EVIO Labs Portland in Tigard, OR continues to provide analytical testing services to cannabis, CBD and hemp producers statewide, as well as hemp and CBD clients nationwide. HempTesting.com customers are being served from our Berkeley, CA and Portland, OR locations. Keystone Labs continues to serve Canadian cannabis, hemp and CBD customers across Canada.
Forward-Looking Statements
Statements contained in this current report that are not statements of historical fact are intended to be and are hereby identified as “forward-looking statements” for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Generally, forward-looking statements include expressed expectations of future events and the assumptions on which the expressed expectations are based. All forward-looking statements are inherently uncertain as they are based on various expectations and assumptions concerning future events and they are subject to numerous known and unknown risks and uncertainties which could cause actual events or results to differ materially from those projected. The Company undertakes no obligation to update or revise this current report to reflect future developments except as otherwise required by the Securities Exchange Act of 1934.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| EVIO, INC., | ||
| Date: February 3, 2021 | By: | /s/ Lori Glauser |
| Lori Glauser | ||
| Chief Executive Officer | ||
